Physician profile
Lisa Chen
NPI 1508879669
$3,875.69
in general payments reported to CMS, 2019-2025
21 companies · $842 in 2025
The $842 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $840 · 2020: $242 · 2021: $337 · 2022: $339 · 2023: $647 · 2024: $628 · 2025: $842.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,117.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thd America, INC. | $706.29 | 2022-2025 | |
| Ethicon US, LLC | $378.30 | 2019-2025 | Echelon Flex, Smartablatetm System Rf Generator |
| Pacira Pharmaceuticals Incorporated | $353.49 | 2019-2025 | Exparel |
| Intuitive Surgical, INC. | $299.68 | 2021-2025 | |
| Baxter Healthcare | $272.34 | 2024-2025 | Perclot |
| Stryker Corporation | $247.78 | 2019 | |
| Becton, Dickinson and Company | $202.24 | 2024 | Hemosphere |
| Aroa Biosurgery Incorporated | $167.05 | 2025 | |
| Tela Bio, INC. | $164.90 | 2019-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Davol INC. | $139.66 | 2023 | Arista Ah Flexitip |
| Edwards Lifesciences Corporation | $133.93 | 2019 | |
| Medtronic, INC. | $123.40 | 2023 | Signia |
| Convatec INC. | $117.20 | 2022 | |
| Integra Lifesciences Corporation | $114.64 | 2021 | |
| Novo Nordisk INC | $107.02 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $106.30 | 2019 | |
| Shire North American Group INC | $105.79 | 2019 | |
| Covidien LP | $74.50 | 2020 | |
| Abbvie INC. | $34.80 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $20.53 | 2020 | |
| Romark Laboratories, Lc | $5.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.